✦ LIBER ✦

Reply to Is There an Optimal Comorbidity Index for Prostate Cancer?

✍ Scribed by Shabbir M. H. Alibhai; Neil E. Fleshner; Gary Naglie

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 62 KB
Volume: 113
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.23665

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is There an Optimal Comorbidity Index fo

Is There an Optimal Comorbidity Index for Prostate Cancer?

✍ Tommaso Cai; Riccardo Bartoletti 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Is there an optimal comorbidity index fo

Is there an optimal comorbidity index for prostate cancer?

✍ Shabbir M. H. Alibhai; Marc Leach; George A. Tomlinson; Murray D. Krahn; Neil E. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

## Abstract ## BACKGROUND. Comorbidity is an important consideration in oncology practice, particularly among older patients. Although a variety of comorbidity indices have been employed in research studies, it is unclear whether any one index is preferred. ## METHODS. An age‐stratified random s

The EORTC studies: is there an optimal e

The EORTC studies: is there an optimal endocrine management for M1 prostatic cancer?

✍ M. R. G. Robinson; J. Hetherington 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 388 KB

Reply to Intra-arterial chemotherapy for

Reply to Intra-arterial chemotherapy for head and neck cancer : Is there a verdict?

✍ K. Thomas Robbins; Stephen B. Howell 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Volumes of normal ovaries, ovaries with

Volumes of normal ovaries, ovaries with benign lesions, and ovaries with cancer in menopausal women: Is there an optimal cut-off value to predict malignancy?

✍ Rami Aviram; Gilad Gassner; Ofer Markovitch; Ilan Cohen; Ami Fishman; Ronnie Tep 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

## Abstract ## Purpose: To evaluate different ovarian volume cut‐off values to distinguish between normal ovaries, benign lesions, and malignant lesions in menopausal women. ## Methods: Transvaginal sonographic ovarian volume measurements were performed in 362 menopausal patients prior to gyneco

Is it time to develop an optimal endocri

Is it time to develop an optimal endocrine therapy for premenopausal patients with axillary node positive and negative breast cancer?

✍ Malcolm M. Bilimoria; V. Craig Jordan 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 655 KB

One hundred years ago ovarian ablation was shown to be an effective treatment for advanced breast cancer in premenopausal women. Since that time many different treatment modalities have been advocated to improve patient survival. The value of adjuvant ovarian ablation, however, has recently been est